Skip to content

Released May 9, 2023, after the close

10-Q filed May 10, 2023, 40 days after period end · 0001636422-23-000058

Q1 2023 · 10-Q
Revenue$73.87M+8.5% vs Q1 2022+6.8% vs Q4 2022
Net Income-$33.19MN/M vs Q1 2022N/M vs Q4 2022
EPS Diluted-$0.60N/M vs Q1 2022no prior Q4 2022 on file
Operating Income-$34,914,000N/M
Operating Cash Flow-$5,580,000N/M
Free Cash Flowderived-$6,005,000N/M
Margins · derived
Operating margin-47.3%−11.5 pt vs Q1 2022
Net margin-44.9%−11.9 pt vs Q1 2022

What the release said

The release

Same quarter

MetricQ1 2023Q1 2022Q1 2021Q1 2020
Revenue$73.87M$68.09M$55.85M$45.12M
Net Income-$33.19M-$22.46M-$28.37M-$17.49M
EPS Diluted-$0.60-$0.54-$0.65-$0.47

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR